Corrigendum to ‘IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?’ Clinical Biochemistry 61 (2018) 34–39
| Autor: | Petrova, Lucie, Vrbacky, Filip, Lanska, Miriam, Zavrelova, Alzbeta, Zak, Pavel, Hrochova, Katerina |
|---|---|
| Zdroj: | In Clinical Biochemistry January 2019 63:161-161 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect